Perkins Capital Management Inc Oncocyte Corp Transaction History

Perkins Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$1.38 - $2.63 $54,820 - $104,476	-39,725 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$1.2 - $1.89 $21,600 - $34,020	18,000 Added 82.85%	39,725 $55,000
Q1 2020 Apr 29, 2020	BUY	$1.76 - $3.02 $38,236 - $65,609	21,725 New	21,725 $53,000
Q2 2019 Aug 09, 2019	SELL	$2.49 - $5.45 $62,250 - $136,250	-25,000 Closed	0 $0
Q1 2019 Apr 22, 2019	BUY	$1.47 - $5.91 $36,750 - $147,750	25,000 New	25,000 $99,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $256M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Perkins Capital Management Inc with notifications on news.